CA2185524A1 - Ocular tension depressant - Google Patents
Ocular tension depressantInfo
- Publication number
- CA2185524A1 CA2185524A1 CA002185524A CA2185524A CA2185524A1 CA 2185524 A1 CA2185524 A1 CA 2185524A1 CA 002185524 A CA002185524 A CA 002185524A CA 2185524 A CA2185524 A CA 2185524A CA 2185524 A1 CA2185524 A1 CA 2185524A1
- Authority
- CA
- Canada
- Prior art keywords
- alkyl
- alkenyl
- ocular tension
- tension depressant
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000994 depressogenic effect Effects 0.000 title abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000003342 alkenyl group Chemical group 0.000 abstract 3
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 239000003889 eye drop Substances 0.000 abstract 2
- 125000000896 monocarboxylic acid group Chemical group 0.000 abstract 2
- 208000010412 Glaucoma Diseases 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
- 125000003831 tetrazolyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
An eye-drop ocular tension depressant and/or an eye-drop glaucoma remedy containing a compound represented by general formula (I), or a salt, ester and the like thereof, wherein: R1 represents alkyl, alkenyl, or R5-A-B- (R5 being H, alkyl, cycloalkyl or acyl; A being O or S; and B being a single bond or alkylene); R2 represents alkyl, alkenyl or -CR6R7R8 (R6 being OH or alkoxy;
and R7 and R8 each being H, alkyl, alkenyl, alkynyl, cycloalkyl, aryl or aralkyl); R3 represents COOH or -CONR9R10 (R9 and R10 being H or optionally substituted alkyl); and R4 represents COOH, COCOOH or tetrazolyl.
and R7 and R8 each being H, alkyl, alkenyl, alkynyl, cycloalkyl, aryl or aralkyl); R3 represents COOH or -CONR9R10 (R9 and R10 being H or optionally substituted alkyl); and R4 represents COOH, COCOOH or tetrazolyl.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6/45404 | 1994-03-16 | ||
JP4540494 | 1994-03-16 | ||
PCT/JP1995/000444 WO1995024902A1 (en) | 1994-03-16 | 1995-03-16 | Ocular tension depressant |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2185524A1 true CA2185524A1 (en) | 1995-09-21 |
CA2185524C CA2185524C (en) | 2006-12-05 |
Family
ID=37560801
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002185524A Expired - Fee Related CA2185524C (en) | 1994-03-16 | 1995-03-16 | Ocular tension depressant |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2185524C (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU773110B2 (en) * | 1999-12-01 | 2004-05-20 | Sankyo Company Limited | Concomitant drugs for treating glaucoma |
-
1995
- 1995-03-16 CA CA002185524A patent/CA2185524C/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU773110B2 (en) * | 1999-12-01 | 2004-05-20 | Sankyo Company Limited | Concomitant drugs for treating glaucoma |
Also Published As
Publication number | Publication date |
---|---|
CA2185524C (en) | 2006-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0705833A4 (en) | Dc-89 derivative | |
EP0758653A4 (en) | Imidazoquinazoline derivatives | |
TW260673B (en) | ||
ATE240734T1 (en) | PREPARATION OF XANTHINDERIVATES AS A SOLID DISPERSION | |
AU667920B2 (en) | New piperidine derivatives of benzimidazole | |
AU7001596A (en) | Compounds potentiating retinoid | |
EP0992501A3 (en) | Pyridonecarboxylic acid derivatives as antibacterial agents | |
UA35592C2 (en) | acetic acid Derivatives | |
CA2124696A1 (en) | Vasopressin antagonist and oxytocin antagonist | |
EP1031573A4 (en) | Novel benzoylpyrazole compounds, intermediates, and herbicides | |
TW223637B (en) | ||
AU5455996A (en) | New alkoxyaryl compounds, their processes of preparation and the pharmaceutical compositions which contain them | |
MY113518A (en) | Benzothiazolone derivatives | |
MX9604109A (en) | Ocular tension depressant. | |
CA2185524A1 (en) | Ocular tension depressant | |
AU6117698A (en) | Antiviral agents | |
AU740079C (en) | Antirheumatic agents | |
CA2092919A1 (en) | Epoxysuccinamic acid derivatives | |
EP0627425A4 (en) | ||
CA2267376A1 (en) | Process for producing depsipeptide derivatives and novel intermediates therefor | |
IT1282152B1 (en) | APPARATUS TO INSERT THE FILM INSIDE A LOADER | |
EP1561744A3 (en) | Amine derivatives, process for producing the same and their use as antimycotic agent | |
NZ208335A (en) | 2-bromo-4-methylimidazole-5-carboxylic acid esters and herbicidal compositions | |
AU3381395A (en) | Preparation of o-(2-hydroxyalkyl) oximes | |
EP0648743A4 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |